Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Sarah Chamlin MD
Sarah L. Chamlin MD Advisory Board
Jane Grant-Kels MD, FAAD
Jane M. Grant-Kels MD, FAAD Advisory Board
Ashish Bhatia MD, FAAD
Ashish C. Bhatia MD, FAAD Associate Editor
See All Experts
featured
Published in Dermatology

Journal Scan / Review · August 25, 2016

No Association Found Between Biologic Therapies and Risk of MACE in Psoriasis

The British Journal of Dermatology

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Suzanne Tintle MD, MPH

The British Journal of Dermatology
Impact of Biologic Therapies on Risk of Major Adverse Cardiovascular Events in Patients With Psoriasis: Systematic Review and Meta-Analysis of Randomised Controlled Trials
Br J Dermatol 2016 Aug 12;[EPub Ahead of Print], W Rungapiromnan, ZZ Yiu, RB Warren, CE Griffiths, DM Ashcroft

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Recently Updated